Market Tracker

07/27 4:45pm ET

ImmunoGen Inc (NASDAQ:IMGN)

2.92
Delayed Data
As of Jul 27
 +0.14 / +5.04%
Today’s Change
2.68
Today|||52-Week Range
18.78
-78.48%
Year-to-Date
No recent news for ImmunoGen Inc.

Today’s Trading

Previous close2.78
Today’s open2.82
Day’s range2.78 - 2.96
Volume1,428,640
Average volume (3 months)1,907,522
Market cap$242.1M
Dividend yield--
Data as of 3:59pm ET, 07/27/2016

Growth & Valuation

Earnings growth (last year)+14.46%
Earnings growth (this year)-116.28%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+42.82%
P/E ratioNM
Price/Sales14.46
Price/Book6.86

Competitors

 Today’s
change
Today’s
% change
ESPREsperion Therapeutic...+0.46+4.22%
RXDXIgnyta Inc+0.15+2.71%
CYADCelyad SA-0.19-0.77%
BCRXBioCryst Pharmaceuti...+0.41+13.67%
Data as of 3:59pm ET, 07/27/2016

Financials

Next reporting dateAugust 4, 2016
EPS forecast (this quarter)-$0.40
Annual revenue (last year)$85.5M
Annual profit (last year)-$60.7M
Net profit margin-71.01%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Mark J. Enyedy
Chief Financial Officer &
Executive Vice President
David B. Johnston
Corporate headquarters
Waltham, Massachusetts

Forecasts